Settled
134 settled decisions from Delhi High Court - Orders.
Settled Decisions
134 cases | Page 1 of 5
Alkem Laboratories Ltd. v.Martin and Brown Biosciences Pvt. Ltd. & Ors. (in suit); Mr. Vineet Maini & Ors. (in rectification petition)
Alkem Laboratories Ltd. filed a commercial suit and a connected rectification petition against Martin and Brown Biosciences Pvt. Ltd. and others concerning the trademark 'SOMI-MB' (Application No. 5982177 in Class 5). The parties settled their disputes through mediation, executing a Settlement Agreement dated 27.07.2026. The Delhi High Court decreed the suit in favour of Alkem by consent and directed the Registrar of Trade Marks to cancel and expunge the impugned mark within four weeks. The plaintiff waived its claims for damages and costs, and was granted a full refund of court fee under the amended Court Fees Act.
AstraZeneca AB & Anr. v.Zydus Healthcare Limited & Anr.
This was a patent infringement suit filed by Astrazeneca AB and another plaintiff against Zydus Healthcare Limited and another defendant, seeking a permanent injunction restraining the defendants from infringing Indian Patent Nos. IN 205147 and IN 235625. During the pendency of the suit, the parties amicably settled their disputes and entered into a confidential Settlement Agreement. The court allowed the joint application under Order XXIII Rule 3 read with Section 151 CPC, disposed of the suit in terms of the settlement, and directed the registry to draw up the decree sheet incorporating the Settlement Agreement.
AstraZeneca AB & Anr. v.Alkem Laboratories Limited
The plaintiffs, Astrazeneca AB & Anr., filed a suit (CS(COMM) 411/2020) before the Delhi High Court seeking a permanent injunction restraining infringement of Indian Patent Nos. IN 205147 and IN 235625 against Alkem Laboratories Limited. During the pendency of the suit, the parties amicably settled their disputes and entered into a confidential Settlement Agreement. The court allowed the joint application under Order XXIII Rule 3 read with Section 151 CPC, disposed of the suit in terms of the settlement, and directed the Settlement Agreement to form part of the decree.
Natco Pharma Limited v.FMC Agro Singapore Pte. Ltd and Ors
Natco Pharma Limited filed a petition under Section 64 of the Patents Act, 1970 seeking revocation of Indian Patent No. 298645 to the extent of claim 12 against FMC Agro Singapore Pte. Ltd and others. The matter was received on transfer from another court. The petitioner sought to withdraw the petition as the inter se disputes between the parties had been amicably settled pursuant to a Settlement Agreement dated 31.03.2026. The petition along with pending applications was disposed of as withdrawn.
Nokia Technologies Oy v.Asustek Computer Inc & Anr.
Nokia Technologies Oy filed a patent infringement suit against Asustek Computer Inc. concerning Indian Patents No. 424507 and 338105. During the pendency of the suit, the parties entered into a Patent License Agreement adjustable through arbitration to settle their disputes. The court allowed the withdrawal of the suit and the defendants' counterclaim seeking revocation of the patents, granting liberty to both parties to initiate fresh proceedings if the License Agreement is terminated or expires.
AstraZeneca AB & Anr. v.MSN Laboratories Private Limited
This was a patent infringement suit filed by Astrazeneca AB and another plaintiff against MSN Laboratories Private Limited seeking a permanent injunction restraining the defendant from infringing Indian Patent Nos. 205147 and 235625. During the pendency of the suit, the parties amicably settled their disputes and entered into a confidential Settlement Agreement. The court allowed the joint application, recorded the settlement, decreed the suit in terms of the settlement, and granted the plaintiffs a refund of the entire court fees.
Telefonaktiebolaget LM Ericsson (PUBL) v.Gionee Communication Equipment Co Ltd & Anr
Telefonaktiebolaget LM Ericsson (Publ) filed a patent infringement suit against Gionee Communication Equipment Co Ltd and another seeking a permanent injunction restraining the defendants from manufacturing, importing, selling, or advertising mobile devices incorporating AMR, 3G, and EDGE technologies covered by Ericsson's suit patents. During the pendency of the suit, Ericsson and Defendant No. 2 amicably resolved their disputes and executed a Settlement Agreement dated 01.12.2025. The Delhi High Court decreed the suit in terms of the settlement, allowed withdrawal of a connected commercial complaint, and granted the plaintiff a refund of court fees under the Court Fees Act, 1870.
AstraZeneca AB & Anr. v.Intas Pharmaceuticals Limited
The Delhi High Court disposed of a patent infringement suit (CS(COMM) 410/2020) filed by Astrazeneca AB & Anr against Intas Pharmaceuticals Limited, based on a joint application recording an amicable settlement between the parties. The suit concerned alleged infringement of Indian Patent Nos. 205147 and 235625. The court decreed the suit in terms of the Settlement Agreement, which formed part of the decree, and directed refund of the entire court fees to the Plaintiffs.
AstraZeneca AB & Anr. v.USV Private Limited
This was a patent infringement suit filed by Astrazeneca AB and another plaintiff against USV Private Limited seeking a permanent injunction restraining infringement of Indian Patent Nos. 205147 and 235625. During the pendency of the suit, the parties arrived at an amicable settlement and entered into a Settlement Agreement. The court allowed the joint application, decreed the suit in terms of the settlement, and directed the registry to draw up the decree sheet.
Manash Lifestyle Private Limited v.Wella International Operations Switzerland SARL & Anr.
The petitioner, Manash Lifestyle Private Limited, filed a petition under Section 57 of the Trade Marks Act, 1999 seeking cancellation of the trademark ULTIME REPAIR registered in favour of Respondent No. 1 in Class 03 under registration No. 5918380. The parties entered into a Settlement Agreement dated 17.07.2026, and the petitioner filed an application under Section 151 CPC to take the settlement on record and direct removal of the trademark entry. The Delhi High Court allowed the application, took the settlement on record, and directed Respondent No. 2 to remove the trademark from the Register of Trade Marks within four weeks.
Asustek Computer Inc & Anr. v.Nokia Technologies Oy & Anr.
The Delhi High Court disposed of three connected revocation petitions filed by Asustek Computer Inc against Nokia Technologies Oy, pertaining to Indian Patent Nos. 381056, 320467, and 356246. The petitions were withdrawn by Asustek following the parties' entry into a Patent License Agreement adjustable through arbitration to settle their pending disputes. The court allowed withdrawal with liberty to reinstitute revocation or other legal proceedings in respect of the subject patents if required.
Manash Lifestyle Private Limited v.Wella International Operations Switzerland Sarl & Anr.
The Petitioner, Manash Lifestyle Private Limited, filed an application under Section 151 CPC seeking to place on record a Settlement Agreement dated 17.07.2026 executed with Respondent No. 1, and to direct Respondent No. 2 to remove the trademark 'ULTIME SMOOTH' (Registration No. 6343131 in Class 03) from the Register of Trade Marks. The Court found the settlement terms to be lawful and allowed the application. Consequently, the petition filed under Section 57 of the Trade Marks Act, 1999 was allowed, and the registration of the trademark 'ULTIME SMOOTH' in favour of Respondent No. 1 was cancelled, with Respondent No. 2 directed to remove the entry from the Register within four weeks.
Asustek Computer Inc & Anr. v.Nokia Technologies Oy & Anr.
The Delhi High Court disposed of a patent revocation petition filed by Asustek Computer Inc. against Nokia Technologies Oy's Indian Patent No. 387206 under Section 64 of the Patents Act, 1970. During the pendency of the proceedings, the parties entered into a Patent License Agreement adjustable through arbitration to settle their disputes. The Court permitted the Petitioners to withdraw the revocation petition with liberty to re-institute proceedings if so required.
Torrent Pharmaceuticals Ltd v.Astrazeneca Ab And Ors
Torrent Pharmaceuticals Ltd. filed a revocation petition under Section 64 of the Patents Act, 1970, seeking revocation of Patent No. IN235625 (3573/DELNP/2004) held by AstraZeneca AB. The petitioner subsequently filed an application to withdraw the petition in light of a settlement reached between the parties in a related suit, CS(COMM) 323/2020. Respondent No. 1 raised no objection to the withdrawal, and the court allowed the application and disposed of the revocation petition as withdrawn along with all pending applications.
Novartis Ag v.Eris Lifesciences Limited
The suit concerned alleged infringement of Patent No. 229051 by the Defendant regarding Valsartan and Sacubitril products. Since the subject patent IN'051 expired, the parties reached an amicable settlement which was recorded by the court.
Incyte Holdings Corporation v.Intas Pharmaceuticals Ltd
The suit was filed alleging infringement of Patent No. 269841 (IN'841) by Intas Pharmaceuticals Ltd regarding the compound Ruxolitinib. After discussions, the Defendant provided an undertaking that they would not commercialize the patented compound during the patent's validity. The court accepted this undertaking and disposed of the suit on consent terms.
Sanjay Mehra v.Deepak Kumar Sharma & Ors.
In a significant trademark dispute, Sanjay Mehra successfully secured a decree against Deepak Kumar Sharma & Ors. through an amicable out-of-court settlement. The Defendants acknowledged that all rights to the 'SUPERON' mark belonged exclusively to the Plaintiff and agreed to cease all use of the mark, including preventing future registrations or similar usage. This resolution allows the suit to be decreed in favor of the Plaintiff while also granting a refund of court fees due to the early settlement.
M/S Tej Ram Dharam Paul v.Sunder Lal Goyal & Anr.
The Delhi High Court accepted a compromise reached between the Plaintiff and Defendant No. 1 in their suit concerning intellectual property rights. The settlement mandates that Defendant No. 1 must suffer a decree of permanent injunction and undertake to withdraw specific trademark applications. The court formally decreed the suit based on these terms, effectively resolving the dispute through mutual agreement.
Incyte Holdings Corporation v.Sun Pharmaceutical Industries Limited
The plaintiffs filed a quia timet action alleging infringement of their patent (IN'841) covering the drug 'Ruxolitinib', marketed as JAKAVI®. The defendants denied commercialization and requested protection under Section 107A. Both parties agreed to settle, with the defendant undertaking not to commercially exploit the compound during the patent's validity.
Incyte Holdings Corporation v.Torrent Pharmaceuticals Limited
Incyte Holdings Corporation filed a quia timet action alleging that Torrent Pharmaceuticals Limited was about to infringe its Indian Patent No. 269841, which covers the compound Ruxolitinib (marketed as JAKAVI®). The parties reached an agreement where the defendant committed not to commercially manufacture or deal in products containing Ruxolitinib during the patent's validity, while retaining rights for research purposes.
Docbel Industries & Anr. v.Braun Aktiengesellschaft
The Delhi High Court disposed of the dispute between Docbel Industries and Braun Aktiengesellschaft based on a comprehensive settlement agreement. The court accepted the compromise, which involved the formal assignment of Trademark registration no. 405367 (the mark BRAUN) from Appellant No. 2 to the Respondent. Furthermore, the parties agreed to the handover of all related documents and financial considerations, effectively resolving the underlying litigation.
J S F Holdings Pvt Ltd v.Assistant Registar Of Trade Marks And Gi & Anr.
The Delhi High Court successfully mediated and settled disputes concerning trademark opposition appeals. Following a successful settlement agreement, the court disposed of the appeals and decreed the underlying suit based on the mutually agreed-upon terms. This judgment highlights the effectiveness of judicial mediation in resolving complex IP conflicts efficiently, allowing parties to achieve tailored resolutions rather than proceeding through lengthy litigation.
Filmtec Corporation & Anr. v.Anil Kumar Ashok Bhaivaswani Owner At Messrs Jal Blue Impex & Ors.
The Delhi High Court disposed of the suit between Filmtec Corporation and Anil Kumar Ashok Bhaivaswani and others following a comprehensive settlement agreement. Defendant No. 1 acknowledged ownership of Filmtec's trademarks (FILMTEC®, DUPONT, etc.) and copyrights, agreeing to cease all infringing activities. The court decreed the suit based on these terms, which included injunctions against Defendants 2 and 3 and payment of litigation costs by Defendant No. 1.
Kluster Llc & Anr. v.Mr. Deval Ravindrabhai Bambhaniya & Ors.
The Delhi High Court decreed a suit between Kluster Llc & Anr. and Mr. Deval Ravindrabhai Bambhaniya & Ors., formalizing an amicable settlement reached by the parties. The defendants acknowledged Kluster's proprietary rights over the 'KLUSTER' mark, trade dress, and copyrighted material. In exchange for a decree, the defendants agreed to cease all use of the infringing marks/designs, refrain from copying original works, and pay Rs. 3,00,000/- in litigation costs.
Sterlite Technologies Limited v.Aberdare Technologies Private Limited
The plaintiff filed a suit seeking permanent injunction and damages for infringement of two patents related to optical fiber production. The defendants filed a counterclaim seeking revocation of these same patents. Both parties subsequently entered into a settlement agreement.
Grasim Industries Limited & Anr. v.Mridula Kumari Trading As M/S Superior Birla Rock And Co.
Grasim Industries Limited successfully settled its trademark infringement suit against Mridula Kumari Trading As M/S Superior Birla Rock And Co. The parties reached an amicable agreement where the defendant formally recognized the plaintiffs' exclusive proprietary rights in trademarks like BIRLA and BIRLA WHITE, trade dress, and packaging. Crucially, the settlement mandates that the defendant cease using any confusingly similar marks or trade names, change her business name, and refrain from online misuse of the protected brands. The court decreed the suit based on these comprehensive settlement terms.
Modi-Mundipharma Pvt. Ltd. v.Agrosaf Pharmaceuticals Pvt. Ltd. & Anr.
The Delhi High Court decreed a trademark infringement suit between Modi-Mundipharma Pvt. Ltd. and Agrosaf Pharmaceuticals Pvt. Ltd. following an amicable settlement. The defendants agreed to permanently cease all use, promotion, and sale of products bearing the mark 'AGROCONTIN.' Furthermore, they acknowledged the plaintiff's proprietary rights in 'NITROCONTIN' and committed not to adopt any deceptively similar marks incorporating the suffix 'CONTIN,' effectively resolving the dispute through a binding decree.
Dcm Shriram Limited v.Mr Sanjay Tada
Dcm Shriram Limited successfully concluded its intellectual property dispute against Mr. Sanjay Tada through an amicable settlement before the Delhi High Court. The court decreed the suit based on the parties' undertaking, which required the defendant to acknowledge all of the plaintiff's trademark and copyright rights. Crucially, the defendant agreed to cease using infringing marks like '303', destroy all related materials, and change packaging for agricultural seeds.
Mars Incorporated v.Cadbury (India) Ltd & Ors
After nearly twenty-five years of protracted litigation over the trademark 'CELEBRATIONS,' Mars Incorporated and Cadbury (India) Ltd have reached a full and final amicable settlement. The Delhi High Court decreed the suit based on this mutual consent, which mandates both parties to withdraw various pending opposition and rectification proceedings before the Trade Marks Registry. Furthermore, in a gesture of goodwill, they jointly undertook to distribute confectionery assortments worth five lakhs each to schoolchildren across Delhi.
Chugai Seiyaku Kabushiki Kaisha v.Anthem Biosciences Limited
The dispute involved Chugai Seiyaku Kabushiki Kaisha alleging infringement of its patent (IN 294424) concerning Alectinib against Anthem Biosciences Limited. The parties subsequently agreed to amicably resolve the matter.
Facing a similar IP matter?
Arctic Invent is a specialist IP firm with deep litigation expertise across India, EU, US, and UK. Our team uses data-driven strategy to build stronger cases.